Literature DB >> 18751878

Psycho-social counselling in predictive genetic testing for cancer: the association between number of supportive sessions and client characteristics as assessed by psycho-social workers.

E D Mollema1, E M A Smets, M E Richard, A M Schiphorst, N J Leschot.   

Abstract

Given the increased demand on genetic services, it is important to identify clients who may require relatively more extensive psychosocial support. This paper describes which client characteristics, as assessed in the first psycho-social counselling session, were associated with requiring relatively more psycho-social support (> or = 3 sessions) in the process of predictive testing for cancer. The study population consisted of 244 counselees for hereditary cancer. Data were derived from an electronic data-base, used by psycho-social workers for the systematic registration of relevant details of each counselling session. Data were analysed for two respective groups: (A) patients who had a known mutation in the family and (B) patients with an as yet unknown mutation in the family. Results show that two or more psychosocial sessions were given if the information derived from the first session indicated the client to have childhood experiences with cancer (in group A), to experience the family role and/or the psychological impact as burdensome (in both groups) or to experience the social impact as burdensome (in group B). We conclude that the first assessment by a psychosocial worker already provides valuable information on the psychological support needs of patients. These findings provide insight into possible problem areas for clients dealing with predictive genetic testing.

Entities:  

Mesh:

Year:  2008        PMID: 18751878     DOI: 10.1007/s10897-008-9166-z

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  37 in total

Review 1.  Communicating genetic information in families--a review of guidelines and position papers.

Authors:  Laura E Forrest; Martin B Delatycki; Loane Skene; MaryAnne Aitken
Journal:  Eur J Hum Genet       Date:  2007-03-28       Impact factor: 4.246

2.  Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.

Authors:  P Hopwood; F Keeling; A Long; C Pool; G Evans; A Howell
Journal:  Psychooncology       Date:  1998 Sep-Oct       Impact factor: 3.894

3.  Genetic Testing Considerations in Breast Cancer Patients.

Authors:  L France; J Gray; G Elwyn; M Tischkowitz; K Brain; J Sampson; C Anglim; A Clarke; E Parsons; H Sweetland; R Mansel; P Barrett-Lee; P Harper
Journal:  J Genet Couns       Date:  1999-10       Impact factor: 2.537

4.  A descriptive study of BRCA1 testing and reactions to disclosure of test results.

Authors:  H T Lynch; S J Lemon; C Durham; S T Tinley; C Connolly; J F Lynch; J Surdam; E Orinion; S Slominski-Caster; P Watson; C Lerman; P Tonin; G Lenoir; O Serova; S Narod
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

5.  Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

Authors: 
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

6.  BRCA1 in the family: a case description of the psychological implications.

Authors:  A C DudokdeWit; A Tibben; P G Frets; E J Meijers-Heijboer; P Devilee; J G Klijn; J C Oosterwijk; M F Niermeijer
Journal:  Am J Med Genet       Date:  1997-07-11

7.  Effect on a Dutch family of predictive DNA-testing for hereditary breast and ovarian cancer.

Authors:  A C de Wit; E J Meijers-Heijboer; A Tibben; P G Frets; J G Klijn; P Devilee; M F Niermeijer
Journal:  Lancet       Date:  1994-07-16       Impact factor: 79.321

8.  Psychosocial care in family cancer clinics in The Netherlands: a brief report.

Authors:  E M Bleiker; F J Grosfeld; D E Hahn; C Honing
Journal:  Patient Educ Couns       Date:  2001-05

9.  Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.

Authors:  Sietske J M Homsma; Roeland Huijgen; Saskia Middeldorp; Eric J G Sijbrands; John J P Kastelein
Journal:  Eur J Hum Genet       Date:  2007-10-24       Impact factor: 4.246

10.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.